drugset / Trial / NCT03709992

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

NCT03709992

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.

Timeline

Start
2020-12-18
Primary completion
2024-08-01
Completion
2024-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tamsulosin Other / unclassified 0.4 mg
Comparator Trospium Small molecule 30 mg